Prescriber's Letter

Commentary: Intensive LDL Reduction: What is the Evidence? January 2007

Article: whether patients can use other niacin products in place of Niaspan December 2005

Commentary: Niacin Use: An Update December 2005

Article: Omacor, the first PRESCRIPTION omega-3 fatty acid product October 2005

Other: New Drug: Lovaza (formerly Omacor) (Omega-3 Acid Ethyl Esters) October 2005

Other: FDA Public Health Advisory on Crestor (rosuvastatin) April 2005

Commentary: An Update on Potential New Uses for Statins July 2004

Guideline: ADA Position Statement on Dyslipidemia Management in Adults with Diabetes (2004) June 2004

Guideline: American College of Physicians Clinical Practice Guideline on Lipid Control in the Management of Type 2 Diabetes Mellitus (2004) June 2004

Commentary: Lipid Control in Diabetes: Review of Clinical Practice Guidelines June 2004

Commentary: Rosuvastatin (Crestor) August 2003

Article: more emphasis on reducing "trans fats" in foods August 2003

Article: Pravigard PAC, the first statin and aspirin combo August 2003

Article: Cholesterol 1,2,3 test to measure skin cholesterol July 2002

Article: Advicor, the first combo drug for dyslipidemia February 2002